ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,290 | -29.5% | 10,500 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $14,595 | -12.6% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $16,695 | +26400.0% | 10,500 | +3.8% | 0.00% | -75.0% |
| Q4 2022 | $63 | -99.9% | 10,114 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $68,000 | +6.2% | 10,114 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $64,000 | +36.2% | 10,114 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $47,000 | -7.8% | 10,114 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $51,000 | +2450.0% | 10,114 | +10014.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |